WEED, Inc. reported its financial results for the first quarter of 2026, revealing a net loss of $175,256, a significant reduction from the $440,455 loss recorded in the same period of 2025. The company did not generate any revenue during this quarter, consistent with its historical performance. The decrease in net loss is attributed primarily to a substantial reduction in general and administrative expenses, which fell from $383,268 in Q1 2025 to $67,833 in Q1 2026. Professional fees, however, increased to $90,500 from $45,847, reflecting ongoing legal and accounting costs.

Total operating expenses for the quarter were $163,955, down from $434,737 in the prior year, indicating a strategic effort to streamline operations. The company’s cash position deteriorated, with cash on hand decreasing to $1,795 from $33,130 at the end of 2025. Total assets also declined to $515,713, down $44,193 from the previous quarter, primarily due to the cash reduction. Current liabilities increased to $1,353,240, up from $1,248,267, driven by higher accounts payable and accrued expenses.

In terms of strategic developments, WEED, Inc. continues to focus on its core business of developing cannabis-derived compounds through its subsidiary, Sangre AT, LLC. The company is also pursuing a Cannabis Genomic Study, which aims to create a genetic blueprint of the cannabis plant. Additionally, the company has been integrating assets from its acquisition of Hempirical Genetics, LLC, which includes a proprietary seed bank of over 250 cannabis and hemp strains. The company is actively seeking funding to support these initiatives and to explore potential entry into the hemp and infused beverage markets.

Operationally, WEED, Inc. has not reported any significant changes in customer counts or user statistics, as it has yet to generate revenue. The company maintains its focus on real estate assets, including a notable property in New York, which it views as a cornerstone for future growth. The company has also dissolved certain non-essential international subsidiaries to streamline operations and reduce overhead costs.

Looking ahead, WEED, Inc. acknowledges the challenges it faces, including the need for additional capital to fund operations and the uncertainty surrounding its ability to generate revenue. Management is actively pursuing new products and services while seeking financing options to support its operational needs. The company’s future performance will depend on its ability to secure funding and successfully execute its strategic initiatives in the evolving cannabis market.

About WEED, INC.

Weed, Inc. is a research-focused company developing cannabis and hemp-based products, including genetic studies, clinical trials, and proprietary strains for medical and therapeutic use. It operates globally with subsidiaries in Israel and Australia, aiming to advance cannabinoid-based treatments, genetic breeding, and infrastructure for the cannabis industry. The company emphasizes innovation, intellectual property, and compliance within evolving legal frameworks.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.